Clinical Trial Update: Assessment of Safety and Efficacy of Vilaprisan in Subjects With Uterine Fibroids [Phase 3]

View source ↗

Summary

Phase 3 trial assessing vilaprisan for uterine fibroids has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Vilaprisan (vilaprisan)

Snippet

Sponsor: Bayer | Conditions: Uterine Fibroids | Phase 3 | Status: WITHDRAWN